Surrogacy in Brazil: An Overview of Current Practices and Legal Considerations

1. The applicable legal and regulatory framework

Article 226(7) of the Federal Constitution protects family planning, grounded in human dignity and responsible parenthood, while Article 227 safeguards children’s rights. Law No. 9.263/1996 addresses equal reproductive rights and scientifically accepted conception techniques, subject to clinical assessment and information about risks, advantages, disadvantages and effectiveness. These protections must be applied together with the health and consent requirements of the proposed procedure.

CFM Resolution No. 2.320/2022 is a medical ethical instrument governing physicians; it is not an Act of Congress. Its Annex regulates assisted reproduction and specifically addresses gestational surrogacy. CNJ Provimento No. 149/2023, as amended, regulates the civil-registry route. Neither instrument should be presented as a comprehensive legislative settlement of every contractual, parentage or international dispute.

The Civil Code remains relevant to personality rights, filiation and proof of parentage. Its assisted-conception presumptions in Article 1,597 operate within the statutory language concerning marriage and do not supply a complete code for every family configuration. A proposed arrangement therefore requires identification of the applicable route and the evidence supporting it, rather than reliance on a general assertion that surrogacy is simply legal or illegal.

2. The technique, genetic origin and eligible patients

Gestational surrogacy involves the transfer of an embryo to a woman who will carry the pregnancy for the intended parent or parents. The embryo may be formed through in vitro fertilisation using their gametes, donated material or a combination permitted by the applicable rules. The genetic connection of each participant must be identified accurately; the procedure does not ensure that every intended parent will have a biological link to the child.

Gestational and altruistic describe different aspects of the arrangement. The former concerns the separation between gestation and genetic contribution; the latter concerns its non-commercial character. Under Annex IV(2.2), the egg or embryo donor cannot also be the gestational carrier. Describing every form of surrogacy as compassionate obscures both that restriction and the independent prohibition of profit or commercialisation.

Access is not confined to infertile married heterosexual couples. Annex II refers to legally capable persons requesting treatment within the resolution’s limits, and its explanatory memorandum addresses single-parent and same-sex families. The specific surrogacy provision requires a condition preventing or contraindicating pregnancy. Clinical suitability and the required agreement of those involved must still be established; family status alone neither supplies nor defeats the indication.

The general rules require a possibility of success and a low probability of serious harm to the patient or prospective child. They set 50 as the maximum age for candidates for pregnancy through assisted reproduction, allowing exceptions only on the technical, scientific, clinical and informed-risk basis specified in Annex I(3.2). Assessment of an individual candidate belongs to the responsible medical team; an age threshold is not a substitute for that evaluation.

3. The gestational carrier and the prohibition of commercial arrangements

Annex VII provides that the gestational carrier must have at least one living child and be a blood relative of one of the partners within the fourth degree. Where the kinship requirement cannot be met, authorisation must be sought from the competent Conselho Regional de Medicina (CRM). The relative-only description is therefore incomplete: the resolution expressly provides a regulatory route for a proposed carrier outside that relationship.

The arrangement must have no profit-making or commercial character, and the reproduction clinic may not intermediate the choice of carrier. These are distinct controls. A private agreement cannot dispense with medical requirements or transform a commercial proposal into an acceptable arrangement merely by calling it altruistic. Any proposed financial terms require scrutiny against the actual obligations and the prohibition, rather than an assumption that every payment is permissible.

The prohibition must also be read alongside the patients’ express undertaking to provide treatment and medical follow-up to the carrier through the postpartum period, including multidisciplinary care where necessary. Providing that care is part of the required protection. The resolution does not establish a general entitlement to unrestricted payments under the description of expenses, compensation or reimbursement.

4. Informed consent, clinical records and continuing care

Consent must follow a substantive discussion of the proposed technique, its biological, legal and ethical implications, and the results achieved by the treatment unit. For surrogacy, Annex VII requires specific undertakings and observations in the patient’s clinical record. Documentation should be completed coherently before the relevant treatment stages, while the civil-registration documentation must be arranged during pregnancy as the resolution directs.

The mandatory surrogacy record includes the following distinct elements. Combining them into a generic contract can obscure the different consents, professional findings and responsibilities that the rule requires.

Beyond those mandatory records, independent legal advice for the participants can help identify divergent expectations about parentage, care, privacy, expenses and a possible dispute. That is a planning recommendation, not an additional universal statutory requirement asserted here. The clinic’s permanent medical and laboratory records should remain accurate and traceable; an agreement should not purport to substitute for clinical judgment or the carrier’s legally protected bodily integrity.

5. Parentage and birth registration

Articles 512–515 of the CNJ national code establish an administrative birth-registration route for children conceived through assisted reproduction, without prior judicial authorisation when the applicable requirements are satisfied. Article 512 addresses attendance by the parents and permits one to attend where they are married or in a stable union, with the required documentation. It also expressly accommodates same-sex couples without distinguishing paternal and maternal ancestry in the record.

Article 513 lists the declaração de nascido vivo (DNV), the technical director’s prescribed declaration with an authenticated signature referring to heterologous assisted reproduction and identifying the beneficiaries, and the specified marriage or stable-union documentation when applicable. Provimento No. 237 of 13 July 2026 added the words quando houver to item III. Conjugal documentation must therefore not be presented as an absolute prerequisite excluding a person who has no marriage or stable union to document. The clinical statement must accurately reflect the treatment performed; any difficulty matching the regulatory wording to the actual technique should be resolved with the registry.

For gestational surrogacy, Article 513(1) requires an undertaking signed by the carrier clarifying parentage and provides that her name, although recorded in the DNV as the woman who gave birth, will not appear in the birth register. The clinical record, the declaration of live birth and the civil entry consequently perform different functions. The rule also distinguishes knowledge of biological ancestry from the creation of parentage and its legal effects between a gamete or embryo donor and the child.

Preparing an undertaking during pregnancy is not the ordinary registration of the birth of an unborn child. The civil-registration route requires the relevant evidence of birth; Civil Code Article 2 separately safeguards rights from conception while providing that civil personality begins with live birth. Likewise, intended parentage established through assisted reproduction should not be relabelled automatically as socio-affective maternity: the source of the relationship, the consents and the applicable registration or judicial route must be identified.

6. Reproductive autonomy, protection and the limits of private agreements

The ethical concerns surrounding exploitation and commodification warrant concrete safeguards rather than an unsupported allegation that surrogacy as a category constitutes trafficking. Voluntary participation, information appropriate to the people involved, independent assessment of health, the non-commercial restriction and continuing care all bear directly on the legitimacy of the proposed arrangement. A family relationship does not, by itself, establish that consent is free from pressure.

The intended parents’ reproductive project must coexist with the carrier’s personality rights and bodily integrity and with the child’s protection. Civil Code Articles 11–15 and the constitutional prohibition of coercion in family planning limit the treatment of such matters as disposable contractual interests. Written undertakings are important evidence of informed intention and responsibility; their existence does not establish that every proposed clause is valid or specifically enforceable.

The arrangements should address foreseeable difficulties in care and documentation, including separation or death, without purporting to determine every future legal outcome. Annex V(3) separately requires written instructions before embryo creation concerning the fate of cryopreserved embryos if the patients divorce, dissolve their stable union or die, and whether they wish to donate them. That decision is distinct from consent to a particular transfer and from the subsequent registration of a child.

7. Regulatory exceptions, judicial scrutiny and legislative debate

A CRM authorisation, a judicial decision concerning a disputed restriction and a birth-registration procedure are separate acts. Annex IX places exceptional cases not covered by the resolution before the regional medical council, with an appeal to the CFM. Judicial scrutiny may arise where rights, administrative refusals or the validity of a restriction are contested; it should not be described as a routine court licence universally required before any permitted treatment.

An official TRF3 report published on 20 December 2024 describes a first-instance ruling allowing the procedure in a case involving a same-sex couple and a friend who had no living child, with protection against disciplinary penalties for the professionals involved in that case. This illustrates review of a specific restriction. The report does not establish a generally binding exemption or disclose a verified appellate outcome; the current published CFM text continues to contain the living-child requirement.

Legislative debate also remains distinct from applicable law. The official record for PL 1184/2003, consulted for this article, lists the proposal as awaiting a rapporteur’s opinion in the Câmara dos Deputados’ constitutional committee. A bill, proposed reform or explanatory statement cannot be applied as though it had been enacted. Debate about a fuller framework does not suspend the existing medical, civil-registry and statutory requirements.

8. International arrangements and planning before treatment

The presence of foreign intended parents adds legal questions that the Brazilian medical rules do not determine. Capacity, family status, the suitability of the proposed carrier, necessary regulatory approvals and the registration documents must be examined in the actual circumstances. Clinical acceptance in Brazil does not establish that another country will recognise the same parentage or issue nationality, immigration or travel documents on the same basis. The relevant foreign law requires country-specific verification.

Brazilian conflict rules include the domicile-based provisions of Article 7 of the Lei de Introdução às Normas do Direito Brasileiro and the public-policy limit in Article 17. Where a foreign situation is brought to Brazil, distinguish a foreign birth record from a judicial or qualifying non-judicial decision. Recognition by the Superior Tribunal de Justiça may be necessary under CPC Articles 960–965, subject to statutory or treaty exceptions and the nature of the act. Neither automatic acceptance nor automatic refusal of every foreign surrogacy arrangement can be inferred from those general rules.

For a child born in Brazil, Article 12(I)(a) of the Constitution contains the rule on Brazilian nationality by birth, including its exception concerning foreign parents in the service of their country. Nationality, legal parentage and authority to travel are separate enquiries. Establish the applicable registration and consular requirements before making commitments that depend on a particular passport, departure date or recognition outcome.

A coherent plan should align the medical indication, any CRM decision, the consent and parentage undertakings, the care arrangements and the route for recording the birth. In a cross-border case, obtain coordinated advice on both legal systems before embryo transfer and preserve the complete clinical and legal record. This preparation supports informed decisions and reduces avoidable documentary conflicts; it cannot guarantee treatment success, a particular judgment or recognition abroad.